Catalyst Wire Dossier

Diseases Search Methodology Pricing Log in Sign up free

Diseases · Proliferative Vitreoretinopathy

Proliferative Vitreoretinopathy

📧 Sign up to get email alerts when something new happens for Proliferative Vitreoretinopathy.

Top drugs studied for this disease

Topotecan (3)
5-Fluorouracil (3)
METHOTREXATE (3)
Bevacizumab (2)
Dacorin (1)
Silicone oil (5000 cSt) (1)
Silicone oil (1000 cSt) (1)
Netarsudil (1)
Aldeyra Therapeutics investigational compound (1)
Methotrexate (intravitreal) (1)

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

No documents found for this filter.

Catalyst Wire Dossier

FDA, ClinicalTrials.gov, and EMA — organized by disease, AI-summarized. Daily updates.

Catalyst Wire family

Dossier SEC FDA Frontier Briefing

Stay updated

Website

Daily FDA actions. One-time €1 verification charge; no recurring payment. Confirm by email, unsubscribe anytime.

Data: openFDA, ClinicalTrials.gov, EMA. Analysis by GPT-5-nano. Not medical advice. · Methodology · Privacy · Terms